The purpose of this study is to measure the level of AlloMax™ incorporation (cellular infiltration, collagen production, and neovascularization) in human breast reconstruction. The hypothesis is that the AlloMaxTM will have incorporation equivalent to adjacent breast capsule at the 3-4 month time point.
Study Type
OBSERVATIONAL
Enrollment
60
University of Nevada School of Medicine
Las Vegas, Nevada, United States
RECRUITINGHydroxyproline Concentration
Hydroxyproline will be measured in the AlloMaxTM and adjacent capsule.
Time frame: 3-4 months
Neoangiogenesis
Measure new blood vessels in AlloMaxTM and adjacent capsule
Time frame: 3-4 months
Collagen I and III
Measure collagen I and III in AlloMaxTM and adjacent capsule
Time frame: 3-4 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.